May 12, 2020 / 6:40 AM / 19 days ago

BRIEF-Hamlet Pharma Enters Into Patent Licensing Agreement

May 12 (Reuters) - Hamlet Pharma AB:

* HAMLET PHARMA ENTERS INTO PATENT LICENSING AGREEMENT

* PATENT LICENSING AGREEMENT HAS BEEN SIGNED BETWEEN HAMLET PHARMA AB AND LINNANE PHARMA AB

* AGREEMENT TO SECURE DEVELOPMENT AND COMMERCIALISATION OF BAMLET FOR USE OTHER THAN AS A PHARMACEUTICAL.

* AGREEMENT STIPULATES THAT LINNANE PHARMA AB WILL PAY AN ANNUAL ROYALTY OF 10% OF ITS GROSS INCOME TO HAMLET PHARMA AB AS LONG AS PATENTS PROTECTING USE OF BAMLET ARE VALID Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below